Systematic Literature Review for Evaluating the Effectiveness of Dyslipidemia Examination
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The purpose of this study is to identify the potential for prevention of cardiovascular diseases when examinations of dyslipidemia are conducted for high-risk groups of cardiovascular diseases. A systematic literature review was carried out in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) Group's systematic literature review reporting guidelines, and the search keyword was set to this : dyslipidemia and screening and high and risk and group and prevention and (CHD OR CAD OR CVD OR cardio heart disease OR coronary artery disease OR cardio vascular disease) As a result of the review, patients with diabetes and abnormal cholesterol levels were selected as high-risk groups, and the results of the examination of dyslipidemia in high-risk groups could reduce the possibility of cardiovascular disease. Hence, it is also believed that examination should be conducted in consideration of high-risk groups, and it is suggested that the cost effect of dyslipidemia examination for high-risk groups of cardiovascular diseases will continue.
Abstract
The purpose of this study is to identify the potential for prevention of cardiovascular diseases when examinations of dyslipidemia are conducted for high-risk groups of cardiovascular diseases. A systematic literature review was carried out in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) Group's systematic literature review reporting guidelines, and the search keyword was set to this : dyslipidemia and screening and high and risk and group and prevention and (CHD OR CAD OR CVD OR cardio heart disease OR coronary artery disease OR cardio vascular disease) As a result of the review, patients with diabetes and abnormal cholesterol levels were selected as high-risk groups, and the results of the examination of dyslipidemia in high-risk groups could reduce the possibility of cardiovascular disease. Hence, it is also believed that examination should be conducted in consideration of high-risk groups, and it is suggested that the cost effect of dyslipidemia examination for high-risk groups of cardiovascular diseases will continue.
참고문헌 (16)
- Benson, G, "Medication adherence, cascade screening, and lifestyle patterns among women with hypercholesterolemia : Results from the WomenHeart survey", Journal of Clinical Lipidology, 10(4), pp.937~943 (2016)
- Bhanpuri, N. H, "Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year : an open label, non-randomized, controlled study", Cardiovasc Diabetol, 17(1), pp.56~ (2018)
- Cholesterol Treatment Trialists, C, "Efficacy and safety of more intensive lowering of LDL cholesterol : a meta-analysis of data from 170, 000 participants in 26 randomised trials", Lancet, 376(9753), pp.1670~1681 (2010)
- Gitt, A. K, "Better lipid target achievement for secondary prevention through disease management programs for diabetes mellitus and coronary heart disease in clinical practice in Germany", Current Medical Research and Opinion, 32(3), pp.417~426 (2016)
- Han, K. H, "Cost-effectiveness analysis between statins administered to control dyslidiemia in Koreans", Journal of Lipid and Atherosclerosis, 1(2), pp.87~94 (2012)
- Harbour, R., "A new system for grading recommendations in evidence based guidelines", BMJ, 323(7308), pp.334~336 (2001)
- NECA systematic Literature Review Manual, "Kim, S. Y", NECA, ~, pp.NECA Research Methods Series 1-287 (2011)
- Kotseva, K, "ASPIRE-2-PREVENT : a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK", Heart, 98(11), pp.865~871 (2012)
- Ministry of Health and Welfare, "Cost-effectivenss analysis report of dyslipidemia screening among national health screening program", ~ (2018)
- Moher, D, ". Preferred reporting items for systematic reviews and meta-analyses : the PRISMA Statement", BMJ, 3(3), pp.e123~e130 (2009)
- Pignone, M. P, "Screening and treating adults for lipid disorders", American Journal of Preventive Medicine, 20(Suppl 3), pp.77~89 (2001)
- Ruescas-Escolano, E, "The PROPRESE trial: results of a new health care organizational model in primary care for patients with chronic coronary heart disease based on a multifactorial intervention", Atencion Primaria, 46(Suppl 3), pp.10~15 (2014)
- Statistics Korea, "Death rate statistics", ~ (2018)
- The Korean Society of Lipid and Atherosclerosis, "Treatment guidelines for dyslipidemia", ~ (2018)
- Welch, L. S, "Impact of Secondary Prevention in an Occupational High-Risk Group", Journal of Occupational and Environmental Medicine, 59(1), pp.67~73 (2017)
- Wilhelmsen, L, "The multifactor primary prevention trial in Goteborg, Sweden", Eur European Heart Journal, 7(4), pp.279~288 (1986)